Containing 100 mg of Tulathromycin in each dose, DRAXXIN®antibiotic injection is indicated for treating the 5 major bacterial causes of swine and bovine respiratory disease (SRD / BRD) in addition to several other diseases making it the economical choice for farmers. DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin, 500 mg propylene glycol, 19.2 mg citric acid and 5 mg monothioglycerol. Sodium hydroxide or hydrochloric acid may be added to adjust pH.
Description
Draxxin Injectable Solution is an antibiotic indicated for the treatment of bovine respiratory disease (BRD), infectious bovine keratoconjunctivitis (IBK) and foot rot in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine. Each ml contains 100 mg tulathromycin. The usual recommended dosage of Draxxin is 2.5 mg per kg (1.1 ml per 100 lbs) body weight, given in the neck. Do not administer more than 10 ml SQ per injection site in cattle. One dose provides up to 7-14 days BRD treatment and control. Do not administer more than 5 ml IM per injection site in swine. Not for use in female dairy cattle 20 months of age or older, or in calves to be processed for veal. Tulathromycin.
BRD – Draxxin Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. IBK – Draxxin Injectable Solution is indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis.
Features of Draxxin Cattle Medicine
- Contains active ingredient Tulathromycin.
- Relatively short withdrawal period for both cattle and swine.
- Single dose provides upto 14 days of treatment/control forBovine Respiratory Disease
- Recommended dosage of Draxxin ® is 2.5 mg per kg (1.1 ml per 100 lbs).
- Injected subcutaneously into neck.
Specifications of Draxxin Cattle Medicine
- Store at or below 25°C (77°F)
- Do not administer more than 10 ml SQ per injection site in cattle
- Do not administer more than 5 ml IM per injection site in swine.
- Not to be used in female dairy cattle 20 months of age or older.
- Not to be used in calves scheduled for veal processing.
Withdrawals
Cattle (meat and offal) 22 days
Pigs (meat and offal) 13 days
Sheep (meat and offal) 16 days
Do not use in lactating cattle producing milk for human consumption.
Do not use in pregnant cows or heifers, which are intended to produce milk for human consumption, within 2 months of expected parturition.
Dosage And Administration
Inject subcutaneously as a single dose in the neck at a dosage of 2.5 mg/kg (1.1 mL/100 lb) body weight (BW). Do not inject more than 10 mL per injection site.
DRAXXIN Cattle Dosing Guide
| Animal Weight (Pounds) | Dose Volume (mL) |
| 100 | 1.1 |
| 200 | 2.3 |
| 300 | 3.4 |
| 400 | 4.5 |
| 500 | 5.7 |
| 600 | 6.8 |
| 700 | 8.0 |
| 800 | 9.1 |
| 900 | 10.2 |
| 1000 | 11.4 |
Prices of Draxxin Cattle Medicine
$279.18 – $1,166.92